Ani Pharmaceuticals Stock Market Value
| ANIP Stock | USD 77.36 0.66 0.86% |
| Symbol | ANI |
Can Pharmaceuticals industry sustain growth momentum? Does ANI have expansion opportunities? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating ANI Pharmaceuticals demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.17) | Earnings Share 1.6 | Revenue Per Share | Quarterly Revenue Growth 0.536 | Return On Assets |
ANI Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on ANI's balance sheet. Smart investors calculate ANI Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since ANI Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that ANI Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ANI Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ANI Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ANI Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ANI Pharmaceuticals.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in ANI Pharmaceuticals on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding ANI Pharmaceuticals or generate 0.0% return on investment in ANI Pharmaceuticals over 90 days. ANI Pharmaceuticals is related to or competes with Harrow Health, CanSino Biologics, Qilian International, Tilray, Dermapharm Holding, Green Thumb, and Trulieve Cannabis. ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescrip... More
ANI Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ANI Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ANI Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 15.16 | |||
| Value At Risk | (2.81) | |||
| Potential Upside | 2.77 |
ANI Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ANI Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ANI Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use ANI Pharmaceuticals historical prices to predict the future ANI Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.36) | |||
| Treynor Ratio | (0.49) |
ANI Pharmaceuticals February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.48) | |||
| Mean Deviation | 1.46 | |||
| Coefficient Of Variation | (1,168) | |||
| Standard Deviation | 2.19 | |||
| Variance | 4.8 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.36) | |||
| Treynor Ratio | (0.49) | |||
| Maximum Drawdown | 15.16 | |||
| Value At Risk | (2.81) | |||
| Potential Upside | 2.77 | |||
| Skewness | 1.52 | |||
| Kurtosis | 8.35 |
ANI Pharmaceuticals Backtested Returns
ANI Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0317, which signifies that the company had a -0.0317 % return per unit of return volatility over the last 3 months. ANI Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ANI Pharmaceuticals' Mean Deviation of 1.46, risk adjusted performance of (0.06), and Coefficient Of Variation of (1,168) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.4, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ANI Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding ANI Pharmaceuticals is expected to be smaller as well. At this point, ANI Pharmaceuticals has a negative expected return of -0.0699%. Please make sure to confirm ANI Pharmaceuticals' maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to decide if ANI Pharmaceuticals performance from the past will be repeated in the future.
Auto-correlation | 0.55 |
Modest predictability
ANI Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between ANI Pharmaceuticals time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ANI Pharmaceuticals price movement. The serial correlation of 0.55 indicates that about 55.0% of current ANI Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 8.21 |
Pair Trading with ANI Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ANI Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against ANI Stock
| 0.44 | RO | Roche Holding AG | PairCorr |
| 0.44 | RHO6 | Roche Holding | PairCorr |
| 0.42 | TEV | Teva Pharmaceutical | PairCorr |
| 0.4 | VTRS | Viatris Sell-off Trend | PairCorr |
| 0.38 | C43 | Cosmo Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ANI Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ANI Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ANI Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.